Mosaic Family Wealth LLC Has $813,000 Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)
Mosaic Family Wealth LLC increased its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 5.4% during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 9,793 shares of the pharmacy operator’s stock after buying an additional 501 shares during the period. Mosaic Family Wealth LLC’s holdings in Walgreens Boots Alliance were worth $813,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently modified their holdings of the company. Norges Bank bought a new position in shares of Walgreens Boots Alliance during the fourth quarter worth approximately $649,813,000. Viking Global Investors LP raised its stake in shares of Walgreens Boots Alliance by 562.8% in the fourth quarter. Viking Global Investors LP now owns 7,899,951 shares of the pharmacy operator’s stock worth $653,800,000 after buying an additional 6,708,040 shares during the last quarter. Renaissance Technologies LLC acquired a new stake in shares of Walgreens Boots Alliance during the fourth quarter worth about $159,586,000. Glenview Capital Management LLC acquired a new stake in shares of Walgreens Boots Alliance during the fourth quarter worth about $124,140,000. Finally, UBS Asset Management Americas Inc. raised its stake in shares of Walgreens Boots Alliance by 22.9% in the first quarter. UBS Asset Management Americas Inc. now owns 4,912,489 shares of the pharmacy operator’s stock worth $407,982,000 after buying an additional 914,888 shares during the last quarter. Institutional investors own 61.17% of the company’s stock.
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) traded up 0.56% during midday trading on Monday, reaching $81.51. The company’s stock had a trading volume of 3,249,096 shares. The stock has a market capitalization of $87.22 billion, a price-to-earnings ratio of 20.58 and a beta of 1.25. The firm has a 50-day moving average price of $78.82 and a 200 day moving average price of $82.40. Walgreens Boots Alliance, Inc. has a 52-week low of $75.18 and a 52-week high of $88.00.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, beating the consensus estimate of $1.30 by $0.03. The company had revenue of $30.12 billion during the quarter, compared to analysts’ expectations of $29.72 billion. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The business’s revenue for the quarter was up 2.1% compared to the same quarter last year. During the same period in the previous year, the company earned $1.18 EPS. Equities research analysts predict that Walgreens Boots Alliance, Inc. will post $5.01 EPS for the current fiscal year.
Walgreens Boots Alliance declared that its Board of Directors has initiated a stock buyback plan on Thursday, June 29th that allows the company to repurchase $5.00 billion in shares. This repurchase authorization allows the pharmacy operator to purchase up to 5.9% of its stock through open market purchases. Stock repurchase plans are often an indication that the company’s board believes its stock is undervalued.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 12th. Investors of record on Friday, August 18th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 1.96%. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. The ex-dividend date of this dividend is Wednesday, August 16th. Walgreens Boots Alliance’s dividend payout ratio is currently 37.78%.
Several brokerages recently weighed in on WBA. Morgan Stanley reissued an “overweight” rating and issued a $95.00 price objective on shares of Walgreens Boots Alliance in a report on Monday, July 3rd. Citigroup Inc. reissued a “buy” rating on shares of Walgreens Boots Alliance in a report on Monday, July 3rd. BidaskClub upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Thursday. Guggenheim restated a “buy” rating on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. Finally, Jefferies Group LLC decreased their target price on Walgreens Boots Alliance from $95.00 to $80.00 and set a “buy” rating for the company in a research note on Wednesday, May 31st. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and fourteen have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $90.69.
In related news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction that occurred on Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total transaction of $218,305.44. Following the completion of the transaction, the director now directly owns 19,151 shares in the company, valued at approximately $1,528,058.29. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 13.50% of the stock is owned by corporate insiders.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.